High ANXA8 levels were significantly associated with advanced stages, differentiation grade and nodal metastases, and proposed as a poor prognosis biomarker in epithelial ovarian cancer (Zhu et al., 2020). Here, ANXA8 is linked to ovarian carcinoma.